Return to Video

New nanotech to catch cancer early

  • 0:04 - 0:08
    "You have cancer."
  • 0:09 - 0:14
    Sadly, about 40 percent of us will hear
    those three words within our lifetime,
  • 0:14 - 0:17
    and half will not survive.
  • 0:17 - 0:21
    This means that two of five
    of your closest friends and relatives
  • 0:21 - 0:24
    will be diagnosed
    with some form of cancer,
  • 0:24 - 0:25
    and one will die.
  • 0:27 - 0:29
    Beyond the physical hardships,
  • 0:29 - 0:32
    roughly one-third of cancer
    survivors here in the US
  • 0:32 - 0:34
    will go into debt from treatment.
  • 0:34 - 0:38
    And they're at least two-and-a-half times
    more likely to declare bankruptcy
  • 0:38 - 0:39
    than those without cancer.
  • 0:40 - 0:42
    This disease is pervasive.
  • 0:42 - 0:44
    It's emotionally draining,
  • 0:44 - 0:45
    and for many,
  • 0:45 - 0:47
    financially destructive.
  • 0:48 - 0:52
    But a cancer diagnosis doesn't
    have to be a death sentence.
  • 0:52 - 0:54
    Finding cancer early,
  • 0:54 - 0:55
    closer its genesis,
  • 0:55 - 0:59
    is one of the critical factors
    to improving treatment options,
  • 0:59 - 1:01
    reducing its emotional impact
  • 1:01 - 1:03
    and minimizing financial burdens.
  • 1:04 - 1:05
    Most importantly,
  • 1:05 - 1:06
    finding cancer early --
  • 1:06 - 1:09
    which is one of the primary
    aims of my research --
  • 1:09 - 1:12
    greatly enhances your odds of survival.
  • 1:12 - 1:15
    If we just look at the case
    of breast cancer for example,
  • 1:15 - 1:19
    we find that those who are diagnosed
    and treated at stage one
  • 1:19 - 1:23
    have a five-year survival rate
    of nearly 100 percent --
  • 1:23 - 1:27
    odds that decrease to just 22 percent
    if treated at stage four.
  • 1:28 - 1:33
    And similar trends are found
    for colorectal and ovarian cancer.
  • 1:34 - 1:40
    Now, we're all aware that an early
    diagnosis that is accurate
  • 1:40 - 1:43
    is critical for survival.
  • 1:44 - 1:48
    The problem is that many
    cancer diagnostic tools are invasive,
  • 1:48 - 1:49
    costly,
  • 1:49 - 1:50
    often inaccurate,
  • 1:50 - 1:54
    and they can take an agonizing
    amount of time to get the results back.
  • 1:55 - 1:56
    Still worse,
  • 1:56 - 1:58
    when it comes to some forms of cancer,
  • 1:58 - 2:01
    such as ovarian, liver
    or pancreatic cancer,
  • 2:01 - 2:05
    good screening methods simply don't exist,
  • 2:05 - 2:09
    meaning that often people wait
    until physical symptoms surface,
  • 2:09 - 2:13
    which are themselves already indicators
    of late-stage progression.
  • 2:14 - 2:18
    Like a tornado strike in an area
    without an early warning system,
  • 2:18 - 2:20
    there is no alarm to warn
  • 2:20 - 2:23
    for the danger is already
    at your doorstep ...
  • 2:23 - 2:26
    when your odds of survival
    are greatly reduced.
  • 2:28 - 2:32
    Having the convenience and accessibility
    of regular screening options
  • 2:32 - 2:37
    that are affordable, noninvasive
    and could provide results much sooner,
  • 2:37 - 2:42
    would provide us with a formidable
    weapon in the fight against cancer.
  • 2:43 - 2:46
    An early warning would allow us
    to get out ahead of the disease
  • 2:46 - 2:49
    instead of merely following
    in its relentless wake.
  • 2:49 - 2:51
    And this is exactly what I've been doing.
  • 2:51 - 2:52
    For the past three years,
  • 2:52 - 2:54
    I've been developing technologies
  • 2:54 - 2:56
    that could ultimately aid clinicians
  • 2:56 - 2:59
    with rapid, early-stage
    cancer diagnostics.
  • 2:59 - 3:03
    And I've been fueled by a deep
    scientific curiosity,
  • 3:03 - 3:06
    and a passion to change these statistics.
  • 3:07 - 3:09
    Last year however,
  • 3:09 - 3:12
    this fight became much more personal
  • 3:12 - 3:15
    when my wife was diagnosed
    with breast cancer.
  • 3:16 - 3:20
    It was an experience that added a strong
    and unexpected emotional dimension
  • 3:20 - 3:22
    to these efforts.
  • 3:24 - 3:28
    I know firsthand how life altering
    treatment can be,
  • 3:28 - 3:30
    and I'm keenly aware
    of the emotional havoc
  • 3:30 - 3:33
    that cancer and wreak on a family,
  • 3:33 - 3:36
    which in our case included
    our two young daughters.
  • 3:37 - 3:40
    Because we found it early
    during a routine mammogram,
  • 3:40 - 3:43
    we were able to focus primarly
    on treatment options
  • 3:43 - 3:45
    for the localized tumor,
  • 3:45 - 3:50
    reaffirming to me how important
    an early diagnosis is.
  • 3:51 - 3:54
    Unlike other forms of cancer,
  • 3:54 - 3:57
    mammograms do offer an early stage
    screening option for breast cancer.
  • 3:57 - 4:00
    Still, not everyone has this done,
  • 4:00 - 4:03
    or they may develop cancer before
    the middle age recommendation
  • 4:03 - 4:05
    for having a mammogram.
  • 4:06 - 4:08
    So, there's still a lot
    of room for improvement,
  • 4:08 - 4:10
    even for cancers that do
    have screening options.
  • 4:10 - 4:11
    And of course,
  • 4:11 - 4:14
    considerable benefits
    for those that don't.
  • 4:14 - 4:17
    A key challenge then
    for cancer researchers
  • 4:17 - 4:18
    is to develop methods
  • 4:18 - 4:23
    that make regular screening for many
    types of cancers much more accessible.
  • 4:24 - 4:27
    Imagine a scenario where during
    your regular checkup,
  • 4:27 - 4:31
    your doctor can take a simple,
    noninvasive urine sample,
  • 4:31 - 4:33
    or other liquid biopsy,
  • 4:33 - 4:37
    and present you with the results
    before you even leave the doctor's office.
  • 4:37 - 4:41
    Such a technology could dramatically
    reduce the number of people
  • 4:41 - 4:45
    who slip through the net
    of an early-stage cancer diagnosis.
  • 4:45 - 4:48
    My research team
    of engineers and biochemists
  • 4:48 - 4:51
    is working on exactly this challenge.
  • 4:51 - 4:56
    We're working on ways to frequently
    activate an early-stage cancer alarm
  • 4:56 - 5:00
    by enabling regular screenings
    that would start when a person is healthy
  • 5:00 - 5:04
    so that action could be taken to stop
    cancer the moment it emerges,
  • 5:04 - 5:08
    and before it can progress
    beyond its infancy.
  • 5:09 - 5:12
    The silver bullet in this case
    are tiny vesicles,
  • 5:12 - 5:17
    little escape pods regularly shed
    by cells called exosomes.
  • 5:17 - 5:22
    Exosomes are important biomarkers
    that provide an early-warning system
  • 5:22 - 5:23
    for the development of cancer.
  • 5:24 - 5:27
    And because they're abundantly present
    in just about every bodily fluid,
  • 5:27 - 5:30
    including blood, urine and saliva,
  • 5:30 - 5:34
    they're extremely attractive
    for noninvasive liquid biopsies.
  • 5:35 - 5:37
    There's just one problem.
  • 5:37 - 5:41
    An automated system for rapidly sorting
    these important biomarkers
  • 5:41 - 5:43
    is not currently available.
  • 5:44 - 5:47
    We've created a technology
    that we call nano-DLD
  • 5:47 - 5:50
    that is capable of precisely this:
  • 5:50 - 5:53
    automated exosome isolation
  • 5:53 - 5:56
    to aid rapid cancer diagnostics.
  • 5:56 - 5:59
    Exosomes are the newest
    early-warning weapon,
  • 5:59 - 6:00
    if you will,
  • 6:00 - 6:02
    to emerge on the liquid biopsy front.
  • 6:02 - 6:04
    And they're really, really small.
  • 6:04 - 6:08
    They measure just 30 to 150
    nanometers in diameter.
  • 6:08 - 6:10
    This is so tiny
  • 6:10 - 6:13
    that you could fit about a million
    of them into a single red blood cell.
  • 6:14 - 6:16
    That's roughly the difference
    between a golf ball
  • 6:16 - 6:19
    and a fine grain piece of sand.
  • 6:19 - 6:23
    Once thought to be little bins
    for unwanted cellular waste,
  • 6:23 - 6:26
    it has been found that cells
    actually communicate
  • 6:26 - 6:29
    by producing and absorbing these exosomes
  • 6:29 - 6:31
    which contain surface receptors,
  • 6:31 - 6:32
    proteins
  • 6:32 - 6:36
    and other genetic material
    collected from their cell of origin.
  • 6:37 - 6:39
    When absorbed by a neighboring cell,
  • 6:39 - 6:43
    exosomes release their contents
    into the receiving cell,
  • 6:43 - 6:47
    and can set in motion fundamental
    changes in gene expression --
  • 6:47 - 6:48
    some good --
  • 6:48 - 6:49
    and this is where cancer comes in --
  • 6:49 - 6:50
    some bad.
  • 6:51 - 6:55
    Because they are clothed
    in the material of the mother cell,
  • 6:55 - 6:57
    and contain a sample of its environment,
  • 6:57 - 7:02
    they provide a genetic snapshot
    of that cell's health and its origin.
  • 7:03 - 7:07
    All of these qualities make exosomes
    invaluable messengers
  • 7:07 - 7:10
    that potentially allow physicians
    to eavesdrop on your health
  • 7:10 - 7:12
    at the cellular level.
  • 7:12 - 7:14
    To catch cancer early however,
  • 7:14 - 7:17
    you have to frequently
    intercept these messages
  • 7:17 - 7:20
    to determine when cancer-causing
    troublemakers within your body
  • 7:20 - 7:22
    decide to start staging a coup,
  • 7:22 - 7:25
    which is why regular
    screening is so critical,
  • 7:25 - 7:29
    and why we're developing
    technologies to make this possible.
  • 7:30 - 7:35
    While the first exosome-based diagnostics
    emerged on the market just this year,
  • 7:35 - 7:39
    they are not yet part of mainstream
    healthcare options.
  • 7:40 - 7:41
    In addition to their recent emergence,
  • 7:41 - 7:45
    another factor that's limiting
    their widespread adoption
  • 7:45 - 7:46
    is that currently,
  • 7:46 - 7:49
    no automated exosome
    isolation system exists
  • 7:49 - 7:52
    to make regular screening
    economically accessible.
  • 7:53 - 7:56
    The current gold standard
    for exosome isolation
  • 7:56 - 7:58
    includes ultracentrifugation,
  • 7:58 - 8:01
    a process requiring expensive
    laboratory equipment,
  • 8:01 - 8:02
    a trained lab tech
  • 8:02 - 8:06
    and about 30 hours of time
    to process a sample.
  • 8:07 - 8:12
    We've come up with a different approach
    for achieving automated exosome isolation
  • 8:12 - 8:13
    from a sample such as urine.
  • 8:14 - 8:18
    We use a chip-based, continuous flow
    separation technique
  • 8:18 - 8:21
    called deterministic lateral displacement,
  • 8:21 - 8:23
    and we have done with it
  • 8:23 - 8:26
    what the semiconductor industry has done
    so successfully for the past 50 years.
  • 8:27 - 8:29
    We shrunk the dimensions
    of this technology
  • 8:29 - 8:32
    from the micron scale
    to the true nanoscale.
  • 8:33 - 8:34
    So how does it work?
  • 8:34 - 8:36
    In a nutshell,
  • 8:36 - 8:40
    a set of tiny pillars separated
    by nanoscopic gaps
  • 8:40 - 8:41
    are arranged in such a way
  • 8:41 - 8:44
    that the system divides
    the fluid into streamlines,
  • 8:44 - 8:47
    with the larger cancer-related
    nanoparticles being separated
  • 8:47 - 8:51
    through a process of redirection
    from the smaller, healthier ones,
  • 8:51 - 8:53
    which can in contrast,
  • 8:53 - 8:56
    move around the pillars
    in a zigzag-type motion
  • 8:56 - 8:58
    in the direction of fluid flow.
  • 8:58 - 9:03
    The net result is a complete separation
    of these two particle populations.
  • 9:04 - 9:07
    You can visualize
    this separation process --
  • 9:07 - 9:11
    similar to traffic on a highway
    that separates into two roads,
  • 9:11 - 9:15
    with one road going into
    a low-clearance tunnel under a mountain,
  • 9:15 - 9:17
    and the other road going around it.
  • 9:17 - 9:20
    Here, smaller cars
    can go through the tunnel
  • 9:20 - 9:21
    while larger trucks,
  • 9:21 - 9:23
    carrying potentially hazardous material,
  • 9:23 - 9:25
    are forced to take the detour route.
  • 9:26 - 9:30
    Traffic is effectively separated
    by size and contents
  • 9:30 - 9:32
    without impeding its flow.
  • 9:32 - 9:36
    And this is exactly how our system works
    on a much, much smaller scale.
  • 9:38 - 9:42
    The idea here is that the separation
    process for screening
  • 9:42 - 9:46
    could be as simple as processing
    a sample of urine, blood or saliva,
  • 9:46 - 9:49
    which is a near-term possibility
    within the next few years.
  • 9:49 - 9:54
    Ultimately, it could be used to isolate
    and detect target exosomes
  • 9:54 - 9:58
    associated with a particular
    type of cancer,
  • 9:58 - 10:00
    sensing and reporting
    their presence within minutes.
  • 10:01 - 10:05
    This would make rapid diagnostics
    virtually painless.
  • 10:05 - 10:06
    Broadly speaking,
  • 10:06 - 10:09
    the ability to separate
    and enrich biomarkers
  • 10:09 - 10:13
    with nanoscale precision
    in an automated way,
  • 10:13 - 10:16
    opens the door to better understanding
    diseases such as cancer,
  • 10:16 - 10:20
    with applications ranging from sample
    preparation to diagnostics,
  • 10:20 - 10:23
    and from drug resistance
    monitoring to therapeutics.
  • 10:24 - 10:26
    Even before my wife's bout with cancer,
  • 10:26 - 10:30
    it was a dream of mine to facilitate
    the automation of this process --
  • 10:30 - 10:33
    to make regular screening more accessible,
  • 10:33 - 10:36
    similar to the way Henry Ford
    made the automobile accessible
  • 10:36 - 10:37
    to the general population
  • 10:37 - 10:40
    through development of the assembly line.
  • 10:40 - 10:43
    Automation is the key to accessibility.
  • 10:44 - 10:46
    And in the spirit of the Hoover dream,
  • 10:46 - 10:49
    "a chicken in every pot
    and a car in every garage,"
  • 10:49 - 10:51
    we're developing a technology
  • 10:51 - 10:52
    that could ultimately place
  • 10:52 - 10:55
    an early-warning cancer detection system
  • 10:55 - 10:56
    in every home.
  • 10:56 - 10:58
    This would allow every
    man, woman and child
  • 10:58 - 11:02
    the opportunity to be regularly tested
    while their still healthy,
  • 11:02 - 11:05
    catching cancer when it first emerges.
  • 11:06 - 11:07
    It is my hope and dream
  • 11:07 - 11:11
    to help people around the world
    avoid the high costs --
  • 11:11 - 11:13
    physical, financial and emotional --
  • 11:13 - 11:16
    faced by today's cancer patients ...
  • 11:16 - 11:18
    hardships that I'm well acquainted with.
  • 11:20 - 11:24
    I'm also happy to report that because
    we caught my wife's cancer early,
  • 11:24 - 11:26
    her treatment was successful,
  • 11:26 - 11:28
    and she is now, thankfully, cancer-free.
  • 11:29 - 11:31
    (Applause)
  • 11:36 - 11:41
    It is an outcome that I would like to see
    for everyone with a cancer diagnosis.
  • 11:41 - 11:43
    With the work that my team
    has already done
  • 11:43 - 11:46
    on separation of nanoscale biomarkers
  • 11:46 - 11:49
    for rapid, early-stage cancer diagnostics,
  • 11:49 - 11:52
    I am optimistic that within
    the next decade,
  • 11:52 - 11:54
    this type of technology will be available,
  • 11:54 - 11:58
    helping protect our friends, our family,
    and future generations.
  • 11:59 - 12:03
    Even if we are so unlucky
    as to be diagnosed with cancer,
  • 12:03 - 12:06
    that early-stage alarm will provide
    a strong beacon of hope.
  • 12:06 - 12:08
    Thank you.
  • 12:08 - 12:10
    (Applause)
Titel:
New nanotech to catch cancer early
Sprecher:
Joshua Smith
Beschreibung:

more » « less
Video Language:
English
Team:
closed TED
Projekt:
TEDTalks
Duration:
12:26

Untertitel in English

Revisionen Compare revisions